Sherbrooke, April 20 2020 – Immune Biosolutions, Diex Research, Keyrus Life Science and the Faculty of Medicine and Health Sciences of the…
Sherbrooke, Qc, CA, January 15th, 2020 – Immune Biosolutions, an early-stage biopharmaceutical company focusing on the discovery, engineering and development…
Immune Biosolutions has been selected to present its Edible Antibodies technology in the G20 Young Entrepreneurs Alliance Event in Fukuoka,…
Chief executive officer, FrĂ©dĂ©ric Leduc, will be representing Immune Biosolutions this week at the 24th edition of BIO-Europe in Copenhagen…
Immune Biosolutions Enters into a Research Collaboration and License Agreement with Johnson & Johnson Innovation to Identify and Develop Therapeutic…
After winning a pitch competition earlier this year, Immune Biosolutions’ founders are participating this week in the Futurpreneur’s Growth Accelerator…
CQDM to support a $1.1 million research and development project for Immune Biosolutions’ next-generation of anti-cancer treatment BOSTON, JUNE 6,…
Immune Biosolutions has been selected to present at the 7th International Cancer Cluster Showcase 2018 in Boston during the BIO Convention…
Immune Biosolutions’ team will once again participate to one of the largest life sciences convention in North America. FrĂ©dĂ©ric Leduc,…
Chief Executive Officer, FrĂ©dĂ©ric Leduc, and Chief Scientific Officer, Simon Gaudreau, will be representing Immune Biosolutions next week at the 14th…
Immune Biosolutions, a Canadian biotech company specialized in the discovery and engineering of humanized chicken antibodies, will present its proprietary Nebula Discovery platform…
Immune Biosolutions selected for JLABS @ Toronto Immune Biosolutions is among the 22 growing businesses selected for JLABS @ Toronto….
